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A B S T R A C T
Background: With aging, the human immune system undergoes several changes. The clinical relevance of these changes, however, is relatively unknown. We
investigated immunological aspects of human aging in relation to frailty in the Doetinchem Cohort Study (DCS).
Methods: We calculated a frailty index score based on 36 health parameters for each individual in the DCS with data obtained in the period 2008–2016. The
frailty index was used to define three health groups (‘healthy’, ‘intermediate’, and ‘frail’), stratified by age and sex. In a subcohort (n=289, 60–85 years,
selected by balanced random sampling per frailty group), we collected blood samples between October 2016 and March 2017 to determine absolute numbers of
leukocyte subsets. In addition, cytomegalovirus serostatus was assessed. C-reactive protein (CRP) levels were longitudinally assessed in four consecutive
plasma samples per individual. These samples had been previously collected (1993–2013) as part of the DCS at regular time intervals and spanning a period
of> 15 years.
Results: We observed higher numbers of myeloid derived neutrophils and monocytes in the frail group compared to the healthy group in both men and women, and,
retrospectively, consistently higher CRP concentrations over a period of> 15 years. An increase in CRP concentration with age was found in women, but not in men.
Frailty was not associated with cytomegalovirus serostatus or with changes in lymphoid derived T-, B-, or NK-cell numbers.
Conclusion: Frail elderly, compared to their age- and sex-matched peers, endure a chronic and stable low-grade inflammation, which is associated with a myeloid cell
lineage expansion. These findings could help to monitor clinically significant immunological decline in the elderly.
1. Introduction
The human immune system is made up of sets of various specialized
cells communicating through numerous proteins and other molecules.
These immune cells, cytokines and chemokines work together in a
tightly controlled manner to maintain a healthy balance allowing to
clear infections and other threats, without causing damage to healthy
tissues (Goldszmid and Trinchieri, 2012). However, as people age, this
balance maybe lost, due to the aging process itself and to chronic en-
vironmental stressors (Goldszmid and Trinchieri, 2012; Weyand and
Goronzy, 2016). This could lead, among others, to changes in the cel-
lular composition of the immune system (Carr et al., 2016). In addition,
a disturbed immunological balance with age may manifest as a state of
chronic, low-grade inflammation without imminent signs of an infec-
tion (‘inflammaging’) (Franceschi and Campisi, 2014) which is evi-
denced by elevated inflammatory markers like c-reactive protein (CRP)
and interleukin-6 (IL-6) (Franceschi and Campisi, 2014). This chronic,
low-grade inflammation has been linked to diminished leukocyte cy-
tokine responses and to various chronic diseases such as cardiovascular
diseases, diabetes, Alzheimer, arthritis, and cancer (Shen-Orr et al.,
2016; Rea et al., 2018; Liu et al., 2017).
Despite these insights, it is still poorly understood how and to what
extent such immunological changes affect health and the odds of
reaching old age in good health (“successful” aging). Furthermore, how
frailty relates to the onset and development of chronic low-grade in-
flammation has hardly been studied.
The aim of the present study is to better understand how low-grade
inflammation develops during aging, and how it influences the immune
system and general health. In order to be able to answer such questions,
an observational study with long-term follow-up is necessary. The
Doetinchem Cohort Study (DCS) provides such a unique framework. As
part of the population-based DCS, blood samples have been collected
every five years in the same individuals since 1987 (Picavet et al., 2017;
Verschuren et al., 2008) which were used to measure CRP concentra-
tions. Therefore, a time series of CRP concentrations (CRP trajectories)
was available, covering a timespan of> 15 years per individual. To be
able to analyze the major human immune cell subsets (neutrophils,
monocytes, lymphocytes, B cells, T cells, and NK cells), we collected
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additional peripheral blood samples from 289 participants of the Doe-
tinchem cohort above 60 years old, randomly selected and stratified by
age, sex, and health status. Latent cytomegalovirus CMV infection was
taken into account since it could be a confounding factor when studying
immune aging (Wertheimer et al., 2014; Apoil et al., 2017; Pawelec,
2014). Health status was defined by employing the concept of a frailty
index (Mitnitski et al., 2001; Searle et al., 2008), which we also used in
this study as an outcome measure. Thus, the study presented here aims
to investigate the cross-sectional association of frailty with the numbers
of innate and lymphocyte subsets in peripheral blood and, in addition,
the association of frailty with time trends in CRP levels over the pre-
ceding 15 years in 289 elderly people. With this study, we intended to
gain more insights into the development of low-grade inflammation and
how it affects frailty and aging in both men and women.
2. Methods
2.1. Study design and population
The Doetinchem cohort study (DCS) started in 1987–1991 with a
random sample of the population in and around Doetinchem, a pro-
vincial town in the Netherlands (n= 7768, aged 20–60 years). Since
then, participants have been examined every five years (1993–1997,
1998–2002, 2003–2007, 2008–2012, 2013–2017). At every DCS ex-
amination round, participants answered questionnaires about general
health, lifestyle, and incurred current or previous diseases (Picavet
et al., 2017; Verschuren et al., 2008). In addition, physical examination
was performed and blood samples were taken, as described in detail
elsewhere (Picavet et al., 2017; Verschuren et al., 2008). We used the
latest available data collected in the period 2008–2016 to construct a
frailty index score as a measure of overall health status for each par-
ticipant (see below). The participants were then stratified by age, sex,
and health status (frailty), and thus, by stratified sampling, a DCS
subcohort was selected in order to investigate cellular immune para-
meters. The timeline is provided in Fig. 1a, which shows the temporal
relationships between the different measurements performed in this
study.
2.2. Construction and validation of the frailty index
We constructed a frailty index to quantify health status based on a
methodology developed in previous studies (Searle et al., 2008;
Rockwood et al., 2011; Collerton et al., 2012; Schoufour et al., 2017).
Details and validation of this frailty index can be found in the supple-
mentary materials (Supplementary Methods, Supplementary Table 1
and Supplementary Fig. 1).
2.3. DCS subcohort selection
In order to select a representative subcohort for analyzing the blood
immune cell composition, and to include sufficient numbers of in-
dividuals covering the full spectrum of health status, we first stratified
all DCS participants aged ≥60 years by age category, sex, and health
status based on frailty index score (see Supplementary Fig. 2 for the
stratification scheme). Within each group, we randomly selected equal
numbers of DCS participants for inclusion in our subcohort, aiming to
include approximately 300 individuals, taking into account a number of
exclusion criteria (see below). From each of these DCS subcohort par-
ticipants, a blood sample (30mL) was drawn for analysis of the immune
cell composition.
For stratification, four age categories were used: 60–65 years,
65–70 years, 70–75 years, and > 75 years (75–85 years). Three ‘health
groups’ were defined by using the frailty index score as follows: within
every age category and for each sex separately, participants in the DCS
with the 15% highest score on the frailty index were defined as being
frail, those with the 15% lowest frailty index as being healthy and the
remaining 70% as having an ‘intermediate’ health status.
2.4. Subcohort inclusion and exclusion criteria
As health related deficits tend to accumulate later in life, we only
included participants ≥60 years old on September 1, 2016, as candi-
dates for our study (n= 2860). From these candidates, we excluded
participants without written consent for re-invitation (n=483), with
information available on fewer than 30 out of 36 health deficits due to
missing measurements (n= 37), and participants who had missed two
or more measurement rounds since the start of the DCS in 1987
(n= 53, Fig. 1b). From those remaining, we invited 390 people for
inclusion in our subcohort, 300 of which were willing to participate.
Finally, we excluded people with a severe immunological disease or
those using strong immunosuppressant medications (n= 11), ending
up with including 289 participants (Fig. 1b). Blood withdrawal was
postponed if people had received antibiotics or vaccinations, or had a
fever with temperatures> 38 °C, within two weeks of the scheduled
blood withdrawal.
2.5. Ethical approval
The study was approved by the Medical Ethics Committee of the
University Medical Center (Utrecht, The Netherlands). The participants
gave written informed consent for every DCS round and for this sub-
cohort study separately.
2.6. Blood immune cell composition
From the DCS subcohort participants, fresh whole blood samples
were collected in the morning (non-fasted) in sodium heparin tubes in
the period from September 1, 2016 until March 1, 2017. The samples
were analyzed within 6 h for absolute numbers of leukocyte subsets
(cell counts per μL), which were obtained with a lyse-no-wash protocol
using TruCOUNT® tubes and using a 4-laser LSRII Fortessa X20 flow
cytometer (BD Biosciences). Neutrophil, monocyte, and lymphocyte
populations were defined by side scatter and the fluorochrome con-
jugated antibody CD45(GA90)-OC515 (Cytognos). In addition, lym-
phocyte subsets (T cell, NK cell, and B cell populations) were defined by
CD3(UCHT1)-BV711, CD16(B73.1)-PE, CD56(B159)-APC (all BD
Biosciences), and CD19(J3-119)-PE-Cy7 (Beckman Coulter). For gating
strategy, see Supplementary Fig. 3. In six participants the monocytes
and in seven participants the lymphocytes were not clearly distin-
guishable from debris and therefore these results were excluded from
analysis. Compensation was performed automatically with BDComp
beads (BD Biosciences). Gating of cellular subsets was performed in
FlowJo V10 (FlowJo company, Ashland, OR).
2.7. C-reactive protein (CRP)
Repeated blood samples were taken with a five-year interval be-
tween 1993 and 2012 and frozen at -80 °C (resulting in a total of four
samples per participant). In these samples, high sensitivity CRP levels
had been measured previously by particle-enhanced immunological
agglutination, as described elsewhere (Hulsegge et al., 2016). All
samples from the same person were measured at the same time to re-
duce intra-individual between-assay variation. The entire CRP time
series of four measurements was available for 239/289 participants.
The remaining participants had three (n= 46) or two (n=4) available
CRP measurements.
2.8. Anti-cytomegalovirus antibodies
We quantified CMV antibody concentrations using an in-house de-
veloped multiplex immunoassay (MIA) based on a commercially
available Cytomegalovirus IgG ELISA kit (EUROIMMUN, Germany)
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(Tcherniaeva et al., 2018). In accordance to the ELISA kit manufac-
turer's instructions, a concentration of< 16 relative units (RU) mL−1
was considered seronegative and>22 RU mL−1 was considered ser-
opositive. Two participants were excluded from analysis, since their
concentration remained in the range of 16–22 RU mL−1 after two
consecutive measurements, resulting in an inconclusive serostatus.
2.9. Statistical analysis
Leukocyte numbers were tested for associations with age category,
health group, and sex using the Kruskal-Wallis test. In addition, they
were tested for associations with the frailty index score after adjusting
for age and CMV serostatus using a linear regression model for both
sexes separately. All leukocyte numbers were log transformed in the
regression model since this gave an approximately normal distribution
for all subsets.
To investigate how differences in frailty index at the final time point
were associated with different CRP trajectories over the preceding
15 years, we used a linear mixed model with log-transformed CRP
concentrations as dependent variable and both frailty index and time
elapsed since the first CRP measurement as independent variables. The
model was evaluated for both sexes separately and adjusted for age at
baseline (first CRP measurement). Next, a second model was further
adjusted for education, BMI, and smoking. Additionally, we tested in-
teractions between frailty index and time to analyze whether different
CRP slopes could be observed with different frailty index scores. We
used a random slope and intercept in the models, to take into account
the correlation between repeated measurements within the same
person. CRP concentrations were log transformed to reach an ap-
proximately normal distribution.
As a sensitivity analysis, the models were reevaluated after removing
samples with CRP plasma concentrations>10mg L−1 (to exclude parti-
cipants with possible acute inflammation), and after removing participants
with joint inflammation and with cardiovascular diseases.
Finally, we investigated how CRP concentrations were associated
with the cellular immune composition. For this purpose we transformed
the cell numbers into z-scores and used these as independent variables
in a linear mixed model, again with (log-transformed) CRP as the de-
pendent variable.
All statistical analyses were performed in R version 3.5.1. The package
lme4 (v1.1-21) was used for linear mixed effects modeling. The package
sjPlot (v2.6.2) was used to produce tables for the regression models and to
calculate p-values for the linear mixed models using the Kenward-Roger
approximation. The package ggplot2 (v3.1.1) was used to create graphics.
A p-value below 0.05 was considered statistically significant.
3. Results
3.1. Baseline characteristics
As shown in Table 1, age and sex distribution were similar between
health categories due to the stratified random selection. In addition,
Fig. 1. (a) Timeline of the current study by using the Doetinchem study (DCS) subcohort; (b) selection of the DCS subcohort. Active DCS participants: participants
who participated at least once since 2012. The DCS subcohort contains an equal selection of the participants in the frailty groups ‘healthy’, ‘intermediate’, and ‘frail’.
Reference time point T0 in (a) corresponds to DCS round 5. For 58% of the participants (n= 106), the frailty score was also assessed at T0. For the others (n= 183),
it was assessed more recently (5 years after T0 and thus at DCS round 6). Immune cellular data was obtained from October 2016 until March 2017.
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CMV serostatus was similar among health categories for both men and
women (Table 1). Frail men smoked more often than healthy men.
Furthermore, BMI was higher in the frail group in both men and women
(Table 1).
3.2. The longitudinal associations between CRP concentrations and frailty,
sex, and age
The average time span between the first CRP measurement and the
frailty index assessment was 17.5 ± 2.6 years (mean ± sd). CRP le-
vels in both men and women increased over the observed period from
T-15 to T0, and hence with advancing age (paired t-test between log
(CRP) at T-15 and T0, with a mean CRP level increase of 1.27mg L−1
(95% conf. int: 1.04–1.55, p= 0.02) in men and 1.37mg L−1 (95%
conf. int: 1.12–1.66, p= 0.002) in women). CRP concentrations over
time are shown in Fig. 2 for the three health groups separately. This
Figure shows that the frail group had higher geometric mean CRP
concentrations than the other groups for all four time points. Indeed, a
higher frailty index was associated with higher CRP concentrations in
both men and women in our linear mixed model (p= 0.001 and
p < 0.001, respectively, Table 2). However, only in women this effect
was also found after correcting for education, smoking, and BMI
(p=0.033, Table 2). CRP concentrations at the last time point (T0, see
Fig. 1a) were positively correlated with frailty in both men and women
(p=0.005 and p < 0.001, respectively, Supplementary Fig. 4). In
addition, CRP concentrations increased over time (and thus with age)
when adjusted for frailty in women but no statistically significant effect
was found in men (p= 0.008 and p=0.062 respectively, Fig. 2 and
Table 2). The slope of the CRP trajectories was not affected by the
frailty index score (p value for the interaction between frailty index and
time: 0.93 for men and 0.4 for women, data not shown).
When people with joint inflammation or with cardiovascular dis-
eases were excluded from the analysis (as a sensitivity analysis), higher
CRP concentrations were still associated with frailty in both men and
women (p=0.024 and p= 0.005, respectively, Supplementary Fig. 5
and Supplementary Table 2). Thus, the main outcome was not dis-
proportionately affected by two specific conditions known to increase
CRP concentrations. Furthermore, the outcome did not change after
excluding CRP concentrations higher than 10 to account for possible
acute infections (data not shown).
3.3. The associations between immune cell subsets and health group, age
category, and sex
We compared cell numbers of both myeloid derived (neutrophils
and monocytes) and lymphoid derived (B cells, T cells and NK cells)
immune cell subsets (Table 1, Fig. 3) between the predefined health
groups.
Frail participants had higher numbers of neutrophils compared to
healthy participants (women: p < 0.001, men: p < 0.001) and higher
numbers of monocytes (women: p=0.002, men: p= 0.010, Table 1,
Fig. 3a). In contrast, frailty was not associated with total lymphocyte, B
cell, NK cell or T cell numbers in both sexes. Thus, the composition of
the cellular immune repertoire showed an expansion of the myeloid
lineage but not of the lymphoid lineage with frailty (Fig. 4).
Women had higher numbers of B cells (p < 0.001), T cells
(p < 0.001), and lymphocytes (p=0.008) compared to men, but
lower numbers of monocytes (p= 0.003, Fig. 3a).
Older women had higher numbers of monocytes (p= 0.018) than
younger women, but this age-related difference was not observed in
men (p= 0.435, Fig. 3b). However, both older men and women had
lower numbers of T cells than younger ones (women: p=0.010, men:
p=0.019, Fig. 3b). Age was not associated with absolute numbers of
neutrophils, which was in contrast to the strong association of frailty
with neutrophil numbers. Furthermore, age was not associated with
numbers of lymphocytes, B cells, or NK cells.
3.4. The associations of immune cell subsets with age, frailty, sex, and CMV
serostatus
In the linear regression analyses with frailty and age as continuous
variables and corrected for CMV serostatus, higher numbers of neu-
trophils corresponded with a higher frailty index in both men and
women (Tables 3a and 3b). Similarly, monocyte numbers correlated
positively with the frailty index but statistical significance was reached
in women only (Tables 3a and 3b). Increasing age was associated with
decreasing T cells numbers in both men and women (p=0.005 and
p=0.015, respectively, Tables 3a and 3b), confirming the results of the
analysis in which frailty and age were handled as categorical variables.
In addition, age was associated with decreasing lymphocyte and B cell
numbers in men (p=0.010 and p=0.004, respectively, Table 3a), but
Table 1
Baseline characteristics of the DCS subcohort stratified by sex and frailty group.
Men Women
Healthy Intermediate Frail p value Healthy Intermediate Frail p value
Age in years, mean (SD) 70.2 (6.6) 70.8 (6.8) 70.9 (6.8) 0.835 70.1 (6.6) 70.5 (5.9) 71.4 (0.12) 0.444
Frailty index, mean (SD) 0.01 (0.028) 0.08 (0.040) 0.24 (0.092) Not tested 0.02 (0.020) 0.11 (0.065) 0.29 (0.12) Not tested
BMI in kg m−2, mean (SD) 25.7 (2.1) 27.1 (3.4) 29.3 (4.6) < 0.001 25.3 (3.2) 27.5 (4.2) 29.9 (5.5) < 0.001
Smoking, % (n) 0.037 0.087
Never 50 (26) 28 (12) 22 (11) 38 (20) 29 (12) 27 (13)
Ex-smoker 48 (25) 58 (25) 58 (29) 60 (32) 57 (24) 57 (28)
Current smoker 1.9 (1) 14 (6) 20 (10) 1.9 (1) 14 (6) 16 (8)
Education 0.101 0.219
Low, % (n) 23 (12) 33 (14) 46 (23) 49 (26) 45 (19) 65 (32)
Middle, % (n) 40 (21) 28 (12) 32 (16) 25 (13) 21 (9) 20 (10)
High, % (n) 36.5 (19) 40 (17) 22 (11) 26 (14) 33 (14) 14 (7)
CMV+, % (n) 42 (22) 47 (20) 54 (27) 0.522 62 (33) 55 (23) 55 (27) 0.643
Leukocytes (counts μL−1)
Neutrophils 2447 2691 3374 <0.001 2315 2744 3294 <0.001
Monocytes 201 221 251 0.010 192 207 211 0.002
Lymphocytes 1593 1147 1405 0.855 1520 1516 1334 0.709
T cells 1053 1034 1130 0.587 1231 1241 1260 0.668
B cells 147 123 132 0.510 170 182 188 0.504
NK cells 256 221 222 0.026 233 227 216 0.857
Total, % (n) 36 (52) 30 (43) 34 (50) 37 (53) 29 (42) 34 (49)
Note: Leukocyte numbers are geometric means per group. P-values show outcomes of either Kruskal-Wallis or chi-squared test between health groups and the baseline
characteristic.
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for both sexes, age was not associated with neutrophil or monocyte
numbers. T cell numbers were also higher in CMV seropositive people
for both men and women (p < 0.001 and p=0.010, respectively) and
lymphocytes were higher in CMV seropositive men.
3.5. The associations of CRP concentrations over time with immune cell
composition





































Fig. 2. CRP trajectories over a time period
of approximately 15 years per frailty
group, (a) for each health group and sex
separately, and (b) the general pattern in
geometric mean CRP concentration per
health group and sex. The x-axis displays
the time in years according to the re-
ference time point (T0). This T0 is the
moment of the most recent blood with-
drawal for CRP concentration measure-
ment. For 58% of the participants
(n=106), the frailty score was also as-
sessed at T0. For the others (n= 183), it
was assessed more recently (5 years after
T0). The bold colored lines in (b) show the
geometric mean values per measurement
time point, stratified by sex and frailty
group. The gray lines show the individual
CRP trajectories. (For interpretation of the
references to color in this figure legend,
the reader is referred to the web version of
this article.)
Table 2
Linear mixed effects regression models of CRP concentrations (mg L−1) over time for men and women.
Predictors Log(CRP) in men Log(CRP) in women
Model 1 Model 2 Model 1 Model 2
Estimates CI p Estimates CI p Estimates CI p Estimates CI p
(Intercept) −0.39 −1.37–0.59 0.434 −1.60 −3.06 to −0.14 0.034 −0.46 −1.53–0.61 0.400 −2.49 −3.93 to −1.05 0.001
Frailty index 2.20 0.95–3.45 0.001 0.51 −0.90–1.93 0.476 2.54 1.48–3.61 <0.001 1.27 0.11–2.43 0.033
Age at baseline 0.00 −0.02–0.03 0.634 0.01 −0.01–0.03 0.468 0.01 −0.02–0.03 0.593 0.01 −0.01–0.03 0.248
Time (years after
baseline age)
0.01 −0.00–0.02 0.062 0.01 −0.00–0.02 0.061 0.02 0.00–0.03 0.008 0.02 0.00–0.03 0.011
Education:
intermediate
−0.29 −0.60–0.02 0.072 0.27 −0.07–0.61 0.127
Education: high −0.46 −0.79 to −0.13 0.007 −0.10 −0.44–0.24 0.567
Smoking: ex 0.31 0.02–0.60 0.037 −0.06 −0.35–0.24 0.710
Smoking: current 0.74 0.29–1.20 0.002 0.19 −0.30–0.67 0.450
BMI 0.05 0.01–0.09 0.023 0.07 0.04–0.10 <0.001
Observations 549 549 553 553
Marginal R2/
conditional R2
0.061/0.608 0.142/0.611 0.106/0.608 0.181/0.610
Note: CRP concentrations were log transformed before analysis. Four CRP concentration measurements per person were used, with approximately 5 years between
measurements. Age at baseline: the age at which the first CRP measurement took place. Education: categorical variable with Education level ‘Low’ as reference.
Smoking: categorical variable with smoking level ‘None’ as reference. CI= 95% confidence interval. Note: P-values < 0.05 are displayed in bold and were con-
sidered statistically significant.
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Fig. 3. Absolute numbers of leukocytes for men and women per (a) frailty group and (b) age group. Box plots showing median values and interquartile ranges. ***:
0 < p < 0.001, **: 0.001 < p < 0.01, *: 0.01 < p < 0.05.
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Fig. 4. A cumulative schematic overview of the immune cell composition by health group and sex. The bar chart shows the geometric mean concentration per cell
subset as indicated.
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neutrophils in both sexes (both p < 0.001), but not with numbers of
monocytes, T cells, B cells or NK cells (Supplementary Table 3).
4. Discussion
Our main finding is that in both sexes, an elderly frail population is
characterized by higher numbers of circulating myeloid derived neu-
trophils and monocytes and higher CRP concentrations compared to an
age matched healthy population. Moreover, this study revealed that
CRP concentrations were consistently higher over a period of> 15
years in the frail population. Frailty was not associated with CMV
serostatus or with changes in lymphoid lineage immune cells. The re-
sults suggest that in the frail elderly, chronic low-grade inflammation
induces an expansion of the myeloid lineage. To the best of our
knowledge, this is the first study showing associations between frailty
and CRP trajectories with multiple consecutive CRP measurements
covering a period of> 15 years.
The frailty index that we used to define health status was con-
structed using data from the Doetinchem Cohort Study (DCS). Its
characteristics were found to be consistent with common frailty index
characteristics reported in the literature (Searle et al., 2008; Rockwood
et al., 2011; Collerton et al., 2012; Schoufour et al., 2017). Another
method broadly used to characterize frailty is by defining a particular
frailty phenotype (Fried et al., 2001). Both the frailty index and the
frailty phenotype have been used extensively and while the frailty
phenotype is easier to operationalize, the frailty index generally is su-
perior in predicting adverse outcomes (Rockwood et al., 2007;
Kulminski et al., 2008).
Our study confirms the results of previous studies showing that
elevated CRP concentrations were associated with frailty (Soysal et al.,
2016; Walker et al., 2018). In addition, our findings provide critical
insight into the presence of chronic low-grade inflammation throughout
a major part of the adult human lifetime, in relation to frailty. In a
recent study, Walker et al. (2018) found that rising CRP levels at
midlife, measured at two points in time, increased the risk of becoming
frail later in life. Interestingly, we found that the CRP concentrations
over time (CRP trajectories) evolved more or less at the same pace in
the different health groups. This suggests that the quite stable differ-
ence in CRP trajectories between the frail and the healthy group must
have developed before our first measurements and would thus have
occurred> 15 years ago. In addition, we found that the effect of frailty
on CRP levels over time was stronger in women than in men. In women,
the effect also holds after correcting for several covariates that could
influence CRP levels (education, smoking, BMI). This confirms that
frailty manifests differently in men and women (Gordon et al., 2017)
and shows the importance of investigating them separately when
studying frailty.
The elevated CRP trajectories in the frail found in our study indicate
that a process of long-term lingering inflammation is common in those
who become frail. Lingering inflammation could lead to a skewing of
the hematopoietic stem cell lineage towards the myeloid cell pre-
cursors, as suggested by Kovtonyuk et al. (2016). This is in line with our
findings that myeloid lineage cell numbers were elevated in the frail
population, while lymphoid lineage cell numbers were not. Another
possibility is that with elevated CRP concentrations, monomeric CRP
(mCRP) levels could increase as well. mCRP is a subunit of the penta-
meric native CRP (nCRP) that can be formed either directly in inflamed
tissue or after dissociation of nCRP (Sproston and Ashworth, 2018;
Thiele et al., 2014). mCRP has several pro-inflammatory effects and can
delay apoptosis of neutrophils (Khreiss et al., 2002), which could ex-
plain the positive associations of CRP with neutrophils. Moreover,
mCRP can also bind to monocytes and mediate pro-inflammatory ef-
fects on monocytes through FcγR binding and signaling (Thiele et al.,
2014).
The observed chronic low-grade inflammation-induced expansion of
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results (Baylis et al., 2013; Leng et al., 2009). In one study, the same
association between high numbers of neutrophils and frailty was found,
but not between monocytes and frailty (Collerton et al., 2012). An ex-
planation for these differences could be that those findings pertained to
a much older cohort (85+ years old).
While myeloid cell numbers were associated with frailty, lymphoid
lineage cell numbers were not, which is consistent with previous studies
(Marcos-Perez et al., 2018). These results were not affected by CMV
seropositivity. However, CMV seropositivity was associated with higher
T-cell numbers in both sexes, as expected (Collerton et al., 2012).
To identify frailty related immune differences between men and
women, we performed analyses separately for each sex. This was in-
spired by the notion that auto-immune diseases are more prevalent in
women than in men (Ngo et al., 2014) and that women tend to have a
higher frailty index but generally live longer than men (Gordon et al.,
2017). We observed the same chronic low-grade inflammation-induced
myeloid cell lineage expansion in both sexes, albeit that these patterns
were more pronounced in women than in men. Furthermore, we ob-
served higher T- and B-cell numbers in women, which agrees with
previously reported results (van der Heiden et al., 2016). In addition, in
women we observed a clear increase in CRP concentrations with age,
while in men we did not.
This study has some limitations. One limitation was that CRP levels
were available retrospectively, while health status could only be as-
sessed at around the time of inclusion in the study. Thus, it was not
possible to study CRP levels as a predictor of the development of frailty.
Furthermore, this was an observational study and as such potentially
affected by unaccounted for confounding and selection bias, not al-
lowing conclusions regarding causality. In addition, many components
of our frailty index were self-reported, which could potentially induce
some subjective bias in the results. Furthermore, diseases like cardio-
vascular disease and joint inflammation could potentially be con-
founders in evaluating the association between chronic low-grade in-
flammation and frailty. Our sensitivity analyses, however, showed that
these did not change the main outcomes of this study. Lastly, we were
only able to use CRP to quantify low-grade inflammation over time.
Since inflammation is a multifactorial process, future studies should
follow to confirm our findings with other important inflammatory
biomarkers that have been associated with frailty, like IL-6 (Soysal
et al., 2016).
It has been suggested that chronic low-grade inflammation may
underlie immune dysfunction with aging and associated morbidities
such as infection and cancer. Indeed, low-grade inflammation has been
found to be associated with lower immune cell cytokine responses
(Shen-Orr et al., 2016) and lower Delayed-type Hypersensitivity re-
sponses to varicella zoster virus (Vukmanovic-Stejic et al., 2018).
Monitoring low-grade inflammation may thus be of use in identifying
the development of immune frailty. Our study shows that this type of
inflammation could possibly already be identified in a frail population
of middle-aged adults. Longitudinal studies like ours could help to
clarify the relationship between chronic low-grade inflammation,
dysfunctional immunity, and ‘successful’ or ‘unsuccessful’ aging. This
could open up the possibility to target this inflammatory state at an
early stage for preventing its detrimental effects. Several interventions
have already been proposed to target low-grade inflammation (Xia
et al., 2016; Aspinall and Lang, 2018). Recent attempts to decrease low-
grade inflammation have been successful in improving vaccine re-
sponses after specific anti-inflammatory therapy (Vukmanovic-Stejic
et al., 2018).
In summary, both male and female frail elderly endure a chronic
and remarkably stable low-grade inflammation, which is associated
with a myeloid cell lineage expansion. These results may aid the
monitoring of clinically significant immune decline in the elderly.
Further research is needed on the functionality of the innate and
adaptive immune cells and on additional inflammatory biomarkers over
time to understand better the most relevant changes of the immune
system with progressing age.
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